NovelStem International NSTM
OTC NSTM
$0.01 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

NovelStem International (NSTM) Non Operating Interest Expenses (2021 - 2026)

Updated

NovelStem International's Non Operating Interest Expenses came in at $50,860 for Q2 2026, down 0.9% from $51,319 a year earlier but up 1.6% from the prior quarter.

Analysis

NovelStem International (NSTM) Non Operating Interest Expenses (2021 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, NovelStem International reported Non Operating Interest Expenses of $193,186, down 50.2% year-over-year; for FY2025, it was $256,219, down 39.8% from FY2024.

  • Non Operating Interest Expenses carries a four-year compound annual growth rate of 147.5% (FY2021 to FY2025).
  • Going back by year, Non Operating Interest Expenses was $425,417 in FY2024, $822.00 in FY2023 (-92.5%), $11,018 in FY2022 (+61.4%) and $6,825 in FY2021.
  • The five-year range for quarterly Non Operating Interest Expenses is $407.00 (Q2 2022) to $118,675 (Q4 2024).
  • Year-over-year, Non Operating Interest Expenses has declined for five consecutive quarters, with an average decline of 34.5% over the last six quarters.
  • The fastest year-over-year change in Non Operating Interest Expenses over five years came in Q4 2022 (growth of 127.4%), and the weakest in Q4 2025 (a decline of 59.1%).
  • Business Quant data shows NSTM's Non Operating Interest Expenses at $50,068 (Q1 2026), $48,547 (Q4 2025) and $43,711 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 281.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -462.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -435.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 247.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 NovelStem International 493,324.54 346,279.54 - 50,860.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 50,860.00
Mar 31, 2026 50,068.00
Dec 31, 2025 48,547.00
Sep 30, 2025 43,711.00
Jun 30, 2025 51,319.00
Mar 31, 2025 112,642.00
Dec 31, 2024 118,675.00
Sep 30, 2024 105,336.00
Jun 30, 2024 106,642.00
Mar 31, 2024 94,764.00
Sep 30, 2023 28,450.00
Jun 30, 2023 20,510.00
Mar 31, 2023 7,313.00
Dec 31, 2022 5,476.00
Sep 30, 2022 3,530.00
Jun 30, 2022 407.00
Mar 31, 2022 1,605.00
Dec 31, 2021 2,408.00
Sep 30, 2021 2,205.00
API Access

NovelStem International Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=NSTM&period=max&api_key=YOUR_API_KEY